Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activated neutrophils are terminally differentiated white blood cells that play a central role as effector cells within the innate immune system. Upon activation by infection-, injury-, or cytokine-derived signals—including chemokines like IL‑8—they rapidly migrate from the bloodstream into tissues where they execute multiple antimicrobial functions. These include phagocytosis; degranulation with release of proteases and antimicrobial peptides; generation of reactive oxygen species; secretion of pro-inflammatory mediators; and formation/release of web-like structures called neutrophil extracellular traps (NETs), which immobilize pathogens but can also contribute to tissue damage if dysregulated. Activated neutrophils are implicated not only in host defense against bacteria/fungi but also play complex roles—both protective and pathogenic—in inflammatory diseases such as sepsis, autoimmune disorders, cardiovascular disease/thrombosis via NETs formation, chronic lung conditions like COPD/asthma/bronchiectasis where their overactivity drives pathology. In oncology settings they may either suppress tumor immunity/promote metastasis (“pro-tumoral” N2 phenotype) or exert cytotoxic anti-tumoral effects (“anti-tumoral” N1 phenotype). Therapeutic strategies target their recruitment/mobilization from bone marrow using agents like G-CSF for immunostimulation or CXCR4 antagonists for mobilizing leukemic cells. Drugs that modulate their activation state—including macrolide antibiotics—are being explored especially where excessive NET production contributes to disease severity.
– Stimulation or inhibition of activation pathways including chemokine receptor signaling, ROS production, degranulation, NETosis – Mobilization from bone marrow by disrupting retention signals like CXCL12-CXCR4 axis – Modulation/inhibition of pro-inflammatory functions with anti-inflammatory drugs or targeted nanomedicines
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutrophil (activated state).